Corcept Therapeutics | CORT - Stock

Aktienkurs
56.37
Täglich Wechseln
-1.93 -3.31%
Monatlich
28.23%
Jährlich
-24.92%
Q2 Prognose
55.24




Stock Veränderung Datum
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
ANI Pharmaceuticals USD 143.47M 401K 2026-03
Ardelyx USD 128.02M 110.29M 2026-03
Assertio Holdings USD 24.76M 8.12M 2025-09
Aurora Cannabis CAD 230.56M 8.6M 2025-12
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Canopy Growth CAD 105.56M 3.18M 2025-12
Corcept Therapeutics USD 12.89M 22K 2026-03
Eli Lilly USD 14.53B 785M 2026-03
Esperion Therapeutics USD 104.21M 915K 2026-03
J&J USD 14.58B 392M 2026-03
Knight Therapeutics CAD 95.4M 2.91M 2024-03
Lexicon Pharmaceuticals USD 276K 5K 2026-03
Merck USD 6.48B 179M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.29B 17M 2026-03
Novartis USD 6.42B 114M 2025-09
Omeros USD 712K 266K 2021-09
Pacira USD 150.37M 2.49M 2026-03
Pfizer USD 10.67B 13M 2026-03
Supernus Pharmaceuticals USD 110.77M 1.71M 2026-03
TG Therapeutics USD 129.03M 3.44M 2026-03